The prophylactic effectiveness of two fluoroquinolones on staphylococcus aureus in rabbit eyes
This presentation is the property of its rightful owner.
Sponsored Links
1 / 9

The Prophylactic Effectiveness of Two Fluoroquinolones on Staphylococcus aureus in Rabbit Eyes PowerPoint PPT Presentation


  • 84 Views
  • Uploaded on
  • Presentation posted in: General

The Prophylactic Effectiveness of Two Fluoroquinolones on Staphylococcus aureus in Rabbit Eyes. Balzli C, Caballero A, Tang A, Weeks A, O’Callaghan R University of Mississippi Medical Center, Microbiology Department, Jackson, MS.

Download Presentation

The Prophylactic Effectiveness of Two Fluoroquinolones on Staphylococcus aureus in Rabbit Eyes

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


The prophylactic effectiveness of two fluoroquinolones on staphylococcus aureus in rabbit eyes

The Prophylactic Effectiveness of Two Fluoroquinolones on Staphylococcus aureus in Rabbit Eyes

Balzli C, Caballero A, Tang A, Weeks A, O’Callaghan R

University of Mississippi Medical Center, Microbiology Department, Jackson, MS

The authors of this poster have received research funding and travel expenses from Alcon Laboratories Inc.


Introduction

Introduction

  • Staphylococcus aureus represents a significant infectious agent causing keratitis and endophthalmitis associated with penetrating surgery (i.e. cataract surgery).

  • S. aureus, particularly methicillin-resistant S. aureus (MRSA), infections can be very damaging to the eye and is increasingly difficult to treat.

  • Topical fluoroquinolones are commonly used prophylactically and as treatment for such infections due to their spectrum of coverage and overall activity, as well as their ability to penetrate tissues.


Introduction1

Introduction

  • The effectiveness of fluoroquinolones has been demonstrated many times in experimental MRSA keratitis models.

  • In the past, gauging the bactericidal effectiveness of these drugs on S. aureus in the anterior chamber has relied on in vitro data such as drug concentrations in the aqueous humor and minimum inhibitory concentrations (MIC) because S. aureus typically dies within the rabbit anterior chamber.

  • In these studies, a clinical isolate of MRSA was found to grow in the anterior chamber and was used to quantify the prophylactic bactericidal effectiveness of moxifloxacin and besifloxacin, a new fluoroquinolone, in the rabbit cornea and anterior chamber.


Growth of mrsa 659 in the anterior chamber

Growth of MRSA659 in the Anterior Chamber

USA300 – Community Acquired MRSA(Strain NRS659*)

7

6

5

LogCFU/ml

4

3

2

1

0.5

2

4

6

8

10

Hours Post-Infection

10hr PI

106 CFU inoculum : n ≥ 3 / time point

* Network on Antimicrobial Resistance in S. aureus


Mrsa 659 susceptibility to fluoroquinolones

moxifloxacin

0.06 µg/ml

n = 6

besifloxacin

0.03 µg/ml

MRSA659 Susceptibility to Fluoroquinolones

  • MICs of the commercial ophthalmic formulations of moxifloxacin (0.5%) and besifloxacin (0.6%) were determined.

  • After determining the growth and susceptibility of MRSA659, the prophylactic effectiveness of the two fluoroquinolones were tested in keratitis and endophthalmitis infection models in the rabbit eye.


Prophylactic treatment

Prophylactic Treatment

Topical application of drug (45 µl)

Infect cornea or anterior chamber

Treatment Groups:

0.6% besifloxacin (Besivance) 45 µl

0.5% moxifloxacin (Vigamox) 45 µl

Untreated

30 min

30 min

Rinse eye with PBS

Quantify CFU of anterior chamber


30 minute prophylaxis of mrsa keratitis

30 Minute Prophylaxis of MRSA Keratitis

Inoculation = 106 CFU : n = 4/group

6

5

*

Log CFU/Cornea

4

5.72

± 0.21

4.01

± 0.22

5.98

± 0.05

3

2

Moxifloxacin

Besifloxacin

Untreated

*

- Fewer CFU/cornea than besifloxacin treated or untreated corneas (P ≤ 0.0023)


The prophylactic effectiveness of two fluoroquinolones on staphylococcus aureus in rabbit eyes

30 Minute Prophylaxis of MRSA Endophthalmitis

Inoculation = 106 CFU : n = 8/group

6

5

*

4

Log CFU/ml Aqueous

3

4.80

± 0.17

3.30

± 0.12

5.01

± 0.14

2

1

Moxifloxacin

Besifloxacin

Untreated

*

- Fewer CFU/cornea than besifloxacin treated or untreated corneas (P ≤ 0.0001)


Conclusions

Conclusions

  • Moxifloxacin was highly effective prophylactically for MRSA within the cornea or anterior chamber.

  • Besifloxacin demonstrated insignificant prophylactic effectiveness in the cornea or the aqueous humor compared to untreated eyes.


  • Login